PNH drug candidate gains orphan designation

05:37 EDT 2 Aug 2017 | SmartBrief

A drug candidate developed by Ra Pharmaceuticals to treat paroxysmal nocturnal hemoglobinuria gained FDA orphan drug status.  -More

Original Article: PNH drug candidate gains orphan designation


More From BioPortfolio on "PNH drug candidate gains orphan designation"

Quick Search

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...